Recent news

Promising new treatment for life threatening acute respiratory distress syndrome (ARDS)

20140102_English.pdf (211.7 kt)
20140102_Finnish.pdf (215.6 kt)
20140102_French.pdf (214.7 kt)
20140102_German.pdf (214.2 kt)

Faron receives scientific advise from the EMA on the FP-1201-lyo clinical development

20131220.pdf (36.3 kt)

New data from the ALI/ARDS FPCLI001 study presented at the 2013 European Respiratory Society meeting

20130909.pdf (56.7 kt)
More news...

Faron is a virtual drug company focusing to discovery and development of proprietary new compounds/use for:

  • vasculopathies
  • traumas
  • inflammation
  • metastasis